William Blair Assumes Xenon Pharmaceuticals (XENE) at Outperform
Tweet
Share
E-mailGet Alerts XENE Hot Sheet
Price: $62.35 -2.93%
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
24 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
William Blair analyst Myles Minter assumes coverage on Xenon Pharmaceuticals (NASDAQ: XENE) with a Outperform rating.
For an analyst ratings summary and ratings history on Xenon Pharmaceuticals click here. For more ratings news on Xenon Pharmaceuticals click here.
Shares of Xenon Pharmaceuticals closed at $37.59 yesterday.
You May Also Be Interested In
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Citi Starts Luxshare Precision (2475:HK) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
